LB PHARMACEUTICALS INC (LBRX) Forecast, Price Target & Analyst Ratings

NASDAQ:LBRX • US50180M1080

Current stock price

30.73 USD
-0.04 (-0.15%)
At close:
30.73 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LB PHARMACEUTICALS INC (LBRX).

Forecast Snapshot

Consensus Price Target

Price Target
$46.67
+ 51.85% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q1 / 2026
EPS Estimate
-$0.78
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
86.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$46.67
Upside
+ 51.85%
From current price of $30.73 to mean target of $46.67, Based on 10 analyst forecasts
Low
$31.31
Median
$37.74
High
$81.90

Price Target Revisions

1 Month
7.65%
3 Months
7.65%

Price Target Summary

10 Wall Street analysts provided a forecast for the next 12 months for LBRX. The average price target is 46.67 USD. This implies a price increase of 51.85% is expected in the next year compared to the current price of 30.73.
The average price target has been revised upward by 7.65% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

LBRX Current Analyst RatingLBRX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

LBRX Historical Analyst RatingsLBRX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -5 -4 -3 -2 -1 0 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
86.00%
LBRX was analyzed by 10 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about LBRX.
In the previous month the buy percentage consensus was at a similar level.
LBRX was analyzed by 10 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-10Craig-HallumInitiate Buy
2026-03-27StifelMaintains Buy -> Buy
2025-12-11StifelMaintains Buy -> Buy
2025-10-06Leerink PartnersInitiate Outperform
2025-10-06StifelInitiate Buy
2025-10-06Piper SandlerInitiate Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q1 / 2026
EPS Estimate
-$0.78
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
N/A
Number of Analysts
7

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-9.93%
EPS (3 Months)
-31.72%

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
LBRX revenue by date.LBRX revenue by date.
N/AN/AN/AN/AN/A
226.64%		N/A
76.43%		N/A
78.67%		N/A
51.42%
EBITDA
YoY % growth
LBRX ebitda by date.LBRX ebitda by date.
-11.372M-64.739M
-469.28%		-30.083M
53.53%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
LBRX ebit by date.LBRX ebit by date.
-11.376M-64.83M
-469.88%		-30.404M
53.10%		N/A
-270.10%		N/A
-32.55%		N/AN/AN/A
19.79%		N/A
78.22%		N/A
568.92%		N/A
150.01%
Operating Margin
LBRX operating margin by date.LBRX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
LBRX eps by date.LBRX eps by date.
N/AN/AN/AN/A
-8.96%		N/A
-3.78%		N/A
5.75%		N/A
-28.46%		N/A
22.42%		N/A
73.08%		N/A
566.35%		N/A
68.25%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.78-0.94
67.87%		-1.06
-74.57%		-1.18
-161.12%		-1.26
-62.30%		-1.29
-37.02%		-1.18
-10.47%		-1.14
3.07%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-23.294M-28.759M
-154.77%		-33.044M
-529.89%		-37.134M
-167.73%		-40.746M
-74.92%		-42.187M
-46.69%		-43.694M
-32.23%		-45.271M
-21.91%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

LBRX Yearly Revenue VS EstimatesLBRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 2030 2031 2032 2033 200M 400M 600M
LBRX Yearly EPS VS EstimatesLBRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 -4 6 8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-2.15%
EPS Next 5 Year
-1.21%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

LB PHARMACEUTICALS INC / LBRX Forecast FAQ

What is the price target for LBRX stock?

10 analysts have analysed LBRX and the average price target is 46.67 USD. This implies a price increase of 51.85% is expected in the next year compared to the current price of 30.73.

Can you provide the consensus estimates for LB PHARMACEUTICALS INC next earnings?

The consensus EPS estimate for the next earnings of LB PHARMACEUTICALS INC (LBRX) is -0.78 USD and the consensus revenue estimate is 0 USD.

How many analysts have analysed LB PHARMACEUTICALS INC (LBRX)?

The number of analysts covering LB PHARMACEUTICALS INC (LBRX) is 10.